Veryan Medical is a UK-based Health Care startup that has developed innovative technology to improve the performance of vascular stents by adopting the principle of biomimicry. Founded in 2003 as a technology spin-out from Imperial College, London, Veryan has designed the BioMimics 3D stent based on the pioneering work by Professor Colin Caro. This technology involves adapting a straight stent design to a three-dimensional helical shape, mimicking the natural geometry of the human vascular system. The company's last investment was a Venture Round at 01 June 2017 led by Nesta Ventures.
The BioMimics 3D stent has been clinically proven in a multicenter, randomized clinical trial and received CE Mark approval in November 2012, showcasing its potential to transform the treatment of patients with symptomatic peripheral arterial disease of the lower limbs. Veryan benefits from a highly experienced Board of Directors and a world-class Scientific Advisory Board.
The company's head office is in Horsham, West Sussex, UK, and it operates a research and development facility in Galway, Ireland. Veryan Medical is a member of the Otsuka Medical Devices Group, providing a strong network and support within the industry. Additionally, the company's Quality Management System is certified in compliance with I.S. EN ISO 13485:2012, emphasizing its commitment to maintaining high standards in the development and production of medical devices.
